Dublin, Jan. 24, 2022 (GLOBE NEWSWIRE) -- The "Global Deep Brain Stimulation (DBS) Devices Market, By Product Type (Single-channel Deep Brain Stimulator, Dual-channel Deep Brain Stimulator), By Type (Rechargeable, Non-Rechargeable), By Application, By End User, By Region, Forecast & Opportunities, 2026" report has been added to ResearchAndMarkets.com's offering.
Global deep brain stimulation (DBS) devices market is expected to undergo substantial growth during the forecast period owing to increasing prevalence of neurological disorders around the world. The growing aging population is also a major growth factor for global deep brain stimulation (DBS) devices market as it is more susceptible to neurological disorders like Parkinson's disease, Alzheimer's disease and Epilepsy.
Moreover, rising prevalence of lifestyle dieses like depression and chronic pain is also creating the demand for these devices. With increasing investment on R&D activities in neurological sector, the global deep brain stimulation (DBS) devices market is anticipated to grow further in the coming years.
Deep brain stimulation devices are based on therapy which involves implantation of electrodes within certain areas of the brain. They are extensively used for the treatment of dystonia, Parkinson's disease, essential tremor, stroke recovery, and many others chronic disorders. The potential advantages of deep brain stimulation devices like improved postoperative outcome control and its long-term effectiveness, are further augmenting the market growth. However, global deep brain stimulation (DBS) devices market is also facing some restrains.
The availability of alternative treatment options like drug therapies and surgeries are expected to hamper the market growth during the forecast period. Also, the side effects associated with the use of deep brain stimulation devices such as allergic reaction and tingling or prickling of the skin might limit the growth of this market.
Global deep brain stimulation (DBS) devices market can be segmented based on product type, type, application, end user and region. Based on application, the market can be segmented into obsessive compulsive disorder, Parkinson's disease, essential tremor, epilepsy, dystonia and others. Among them, the Parkinson's disease dominated the global market during the forecast period owing to their growing prevalence, especially among aging population. However, the Obsessive-Compulsive Disorder (OCD) segment is anticipated to undergo highest CAGR through 2026 due to the increasing cases of OCD around the world.
Major companies operating in global deep brain stimulation (DBS) devices market include Boston Scientific Corporation, Abbott Laboratories (St. Jude Medical), Beijing PINS Medical Co. Ltd, Fisher Wallace, NeuroSigma, Inc., Functional Neuromodulation Ltd, Medtronic PLC, NeuroPace Inc., Renishaw PLC, ALEVA NEUROTHERAPEUTICS SA, LivaNova PLC, SceneRay Corporation, Nevro Corporation and Neuronetics Inc. The market players are coming up with new & innovative devices and investing on latest technologies to increase their global market share.
Objective of the Study:
- To analyze and forecast the market size of global deep brain stimulation (DBS) devices market.
- To forecast global deep brain stimulation (DBS) devices market based on product type, type, application, end user, company and regional distribution.
- To identify drivers and challenges for global deep brain stimulation (DBS) devices market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in global deep brain stimulation (DBS) devices market.
- To identify and analyze the profile of leading players operating in the global deep brain stimulation (DBS) devices market.
Key Topics Covered:
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Deep Brain Stimulation (DBS) Devices Market
4. Executive Summary
5. Voice of Customer
6. Global Deep Brain Stimulation (DBS) Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Single-channel Deep Brain Stimulator, Dual-channel Deep Brain Stimulator)
6.2.2. By Type (Rechargeable, Non-Rechargeable)
6.2.3. By Application (Obsessive Compulsive Disorder, Parkinson's Disease, Essential Tremor, Epilepsy, Dystonia, Others)
6.2.4. By End User (Hospitals, Ambulatory Surgical Centers (ASCs), Neurological Clinic, Research Centers)
6.2.5. By Company (2021)
6.2.6. By Region
6.3. Product Market Map
7. Asia-Pacific Deep Brain Stimulation (DBS) Devices Market Outlook
8. Europe Deep Brain Stimulation (DBS) Devices Market Outlook
9. North America Deep Brain Stimulation (DBS) Devices Market Outlook
10. South America Deep Brain Stimulation (DBS) Devices Market Outlook
11. Middle East and Africa Deep Brain Stimulation (DBS) Devices Market Outlook
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Competition Outlook
14.2. Players Profiled
14.2.1. Boston Scientific Corporation
14.2.2. Abbott Laboratories (St. Jude Medical)
14.2.3. Beijing PINS Medical Co. Ltd
14.2.4. Fisher Wallace
14.2.5. NeuroSigma, Inc.
14.2.6. Functional Neuromodulation Ltd
14.2.7. Medtronic PLC
14.2.8. NeuroPace Inc.
14.2.9. Renishaw PLC
14.2.10. ALEVA NEUROTHERAPEUTICS SA
14.2.11. LivaNova PLC
14.2.12. SceneRay Corporation
14.2.13. Nevro Corporation
14.2.14. Neuronetics Inc.
15. Strategic Recommendations
16. About the Publisher & Disclaimer
For more information about this report visit https://www.researchandmarkets.com/r/228emj
